Inventor · disambiguated record
Jill Carton
Also filed as: CARTON JILL · CARTON JILL M · CARTON JILL MARINARI
20 granted patents·18 pending applications·303 citations·filing 2002–2024
95Inventor score
Files withCENTURY THERAPEUTICS INC11JANSSEN BIOTECH INC9BENSON JACQUELINE3CARTON JILL M3BLAKE SIMON2
Top patents by PatentIndex Score
38 records- 0198US7935344B2Human anti-IL-23 antibodies, compositions, methods and usesCENTOCOR ORTHO BIOTECH INC·Filed 2006·Granted May 3, 2011·93 cites·24 claims
- 0297US7993645B2Human anti-IL-23 antibodies, compositions, methods and usesJANSSEN BIOTECH INC·Filed 2010·Granted Aug 9, 2011·57 cites·11 claims
- 0396US8106177B2Nucleic acids encoding human anti-IL-23 antibodiesBENSON JACQUELINE·Filed 2011·Granted Jan 31, 2012·34 cites·16 claims
- 0495US8221760B2Methods of treatment using human anti-IL-23 antibodiesBENSON JACQUELINE·Filed 2011·Granted Jul 17, 2012·29 cites·8 claims
- 0594US10030070B2Human anti-IL-23 antibodies, compositions, methods and usesJANSSEN BIOTECH INC·Filed 2017·Granted Jul 24, 2018·11 cites·11 claims
- 0694US9783607B2Human anti-IL-23 antibodies, compositions, methods and usesJANSSEN BIOTECH INC·Filed 2016·Granted Oct 10, 2017·10 cites·19 claims
- 0794US9353181B2Human anti-IL-23 antibodies, compositions, methods and usesBENSON JACQUELINE·Filed 2012·Granted May 31, 2016·22 cites·9 claims
- 0889US2024199733A1Anti-IL-23 AntibodiesJANSSEN BIOTECH INC·Filed 2024·Application pending·0 cites
- 0987US8399630B2Engineered anti-IL-13 antibodies, compositions, methods and usesSWANSON RONALD V·Filed 2009·Granted Mar 19, 2013·11 cites·5 claims
- 1086US8153583B2Toll like receptor 3 antagonists, methods and usesCARTON JILL M·Filed 2005·Granted Apr 10, 2012·22 cites·9 claims
- 1183US8323646B2Engineered anti-IL-13 antibodies, compositions, methods and usesSWANSON RONALD V·Filed 2009·Granted Dec 4, 2012·7 cites·3 claims
- 1282US7371825B2Anti-MCP-1 antibodies, compositions, methods and usesCENTOCOR INC·Filed 2005·Granted May 13, 2008·5 cites·11 claims
- 1378US12129293B2Medical device for administering anti-IL-23 antibodiesJANSSEN BIOTECH INC·Filed 2021·Granted Oct 29, 2024·0 cites·13 claims
- 1476US8663980B2Vectors, host cells, and methods of production and usesCARTON JILL·Filed 2008·Granted Mar 4, 2014·2 cites·11 claims
- 1575US10954297B2Methods of treatment using human anti-IL-23 antibodiesJANSSEN BIOTECH INC·Filed 2018·Granted Mar 23, 2021·0 cites·10 claims
- 1672US2024216429A1Chimeric antigen receptor system with adaptable receptor specificityCENTURY THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1768US11883432B2Chimeric antigen receptor system with adaptable receptor specificityCENTURY THERAPEUTICS INC·Filed 2021·Granted Jan 30, 2024·0 cites·13 claims
- 1868US2025059286A1Artificial cell death polypeptide for chimeric antigen receptor and uses thereofCENTURY THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1967US12269888B2Artificial cell death polypeptide for chimeric antigen receptor and uses thereofCENTURY THERAPEUTICS INC·Filed 2023·Granted Apr 8, 2025·0 cites·4 claims
- 2066US8980626B2Vectors, host cells, and methods of production and usesJANSSEN BIOTECH INC·Filed 2014·Granted Mar 17, 2015·0 cites·18 claims
- 2162US2025090582A1Genetically engineered cells having anti-cd133 / anti-egfr chimeric antigen receptors, and uses thereofCENTURY THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2260US9206248B2Vectors, host cells, and methods of production and usesJANSSEN BIOTECH INC·Filed 2015·Granted Dec 8, 2015·0 cites·13 claims
- 2358US11661459B2Artificial cell death polypeptide for chimeric antigen receptor and uses thereofCENTURY THERAPEUTICS INC·Filed 2021·Granted May 30, 2023·0 cites·11 claims
- 2456US2025064934A1Genetically engineered cells having anti-cd19 / anti-cd22 chimeric antigen receptors, and uses thereofCENTURY THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2556US2024025992A1Proteins comprising delta-like ligand 3 (dll3) antigen binding domains and their usesJANSSEN BIOTECH INC·Filed 2021·Application pending·0 cites
- 2653US2022331361A1Gene transfer vectors and methods of engineering cellsCENTURY THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2752US7982007B2Cynomolgus toll-like receptor 3CENTOCOR INC·Filed 2008·Granted Jul 19, 2011·0 cites·4 claims
- 2852US2004185047A1Anti- TNF antibodies, compositions, methods and usesFiled 2003·Application pending·0 cites
- 2951US2022333074A1Compositions and Methods for Generating Alpha-Beta T Cells from Induced Pluripotent Stem CellsCENTURY THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3049US2009162375A1Resistin antagonists and their useBLAKE SIMON·Filed 2007·Application pending·0 cites
- 3149US2003157105A1Anti-p40 immunglobulin derived proteins, compositions, methods and usesFiled 2002·Application pending·0 cites
- 3246US2022184123A1Genetically Engineered Cells and Uses ThereofCENTURY THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3346US2022195396A1Genetically Engineered Cells and Uses ThereofCENTURY THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3444US2014255388A1Toll like receptor 3 antagonists, methods and usesCARTON JILL M·Filed 2013·Application pending·0 cites
- 3542US2009117122A1Resistin Antagonists and Their UseCARTON JILL·Filed 2008·Application pending·0 cites
- 3642US2012189643A1Toll Like Receptor 3 Antagonists, Methods and UsesCARTON JILL M·Filed 2012·Application pending·0 cites
- 3736US2011071277A1Resistin antagonists and their useBLAKE SIMON·Filed 2010·Application pending·0 cites
- 3831US2002197654A1Method for measuring serine palmitoyltransferase in mammalian tissue and use thereofFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jill Carton files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →